Non-invasive Potential Circulating mRNA Markers for Colorectal Adenoma Using Targeted Sequencing
Open Access
- 10 September 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Abstract
We have developed an optimized protocol for plasma targeted mRNA sequencing in our previous study. Here, we performed plasma targeted mRNA sequencing for 40 colorectal adenoma patients and 39 colonoscopy-proven normal controls in order to find potential circulating mRNA markers for colorectal adenoma. Results showed thatGSK3AandRHOAwere differential expressed genes identified by a cut-off of fold change >2 and adjustedPvalue < 0.05. More detailed analysis showed that the expression of bothGSK3A(0.01-fold with adjustedP < 1 × 10−6) andRHOA(0.35-fold with adjustedP < 0.01) in adenoma patients was significantly lower than those in normal healthy subjects. Based on the enrichment analysis of biological process for potential markers, we found that the regulation of programmed cell death (GO: 0043067; GO: 0043069), regulation of cell death (GO: 0010941; GO: 0060548) and cell differentiation (GO: 0021861) were the main processes involved in adenoma formation. In summary, this study is a cutting-edge research on the detection of plasma mRNA in colorectal adenoma patients and normal healthy subjects.Keywords
This publication has 30 references indexed in Scilit:
- Multitarget Stool DNA Testing for Colorectal-Cancer ScreeningNew England Journal of Medicine, 2014
- Long-Term Mortality after Screening for Colorectal CancerNew England Journal of Medicine, 2013
- Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopyEuropean Journal of Cancer, 2013
- Ribosomal RNA Depletion for Efficient Use of RNA‐Seq CapacityCurrent Protocols in Molecular Biology, 2013
- Distinct expression and activity of GSK‐3α and GSK‐3β in prostate cancerInternational Journal of Cancer, 2012
- Translating cancer ‘omics’ to improved outcomes: Figure 1.Genome Research, 2012
- Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significanceExpert Review of Molecular Diagnostics, 2011
- Evidence that glycogen synthase kinase‐3 isoforms have distinct substrate preference in the brainJournal of Neurochemistry, 2010
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyCA: A Cancer Journal for Clinicians, 2008